Michelle Gittelman
Michelle Gittelman
Rutgers Business School
Geverifieerd e-mailadres voor business.rutgers.edu
Titel
Geciteerd door
Geciteerd door
Jaar
Patent citations as a measure of knowledge flows: The influence of examiner citations
J Alcacer, M Gittelman
The Review of Economics and Statistics 88 (4), 774-779, 2006
7202006
Does good science lead to valuable knowledge? Biotechnology firms and the evolutionary logic of citation patterns
M Gittelman, B Kogut
Management Science 49 (4), 366-382, 2003
7082003
Applicant and examiner citations in US patents: An overview and analysis
J Alcácer, M Gittelman, B Sampat
Research Policy 38 (2), 415-427, 2009
3272009
Does geography matter for science-based firms? Epistemic communities and the geography of research and patenting in biotechnology
M Gittelman
Organization Science 18 (4), 724-741, 2007
2752007
How do I know what you know? Patent examiners and the generation of patent citations
J Alcacer, M Gittelman
Patent Examiners and the Generation of Patent Citations (August 2004), 2004
1462004
National institutions, public–private knowledge flows, and innovation performance: A comparative study of the biotechnology industry in the US and France
M Gittelman
Research Policy 35 (7), 1052-1068, 2006
1442006
A note on the value of patents as indicators of innovation: Implications for management research
M Gittelman
Academy of Management Perspectives 22 (3), 21-27, 2008
1042008
The revolution re-visited: Clinical and genetics research paradigms and the productivity paradox in drug discovery
M Gittelman
Research Policy 45 (8), 1570-1585, 2016
572016
Mapping national knowledge networks: Scientists, firms, and institutions in biotechnology in the United States and France
M Gittelman
332000
How do I know what you know
J Alcacer, M Gittelman
Patent Examiners and the Generation of Patent Citations, New York University, 2004
302004
What makes research socially useful? Complementarities between in-house research and firm-university collaboration in biotechnology
M Gittelman
Revue d'économie industrielle 110 (1), 57-73, 2005
252005
Research paradigms and useful inventions in medicine: Patents and licensing by teams of clinical and basic scientists in Academic Medical Centers
A Ali, M Gittelman
Research Policy 45 (8), 1499-1511, 2016
242016
Japanese multinationals in Europe and the United States: some comparisons and contrasts
M Gittelman, JH Dunning
Multinationals in the new Europe and global trade, 237-268, 1992
221992
Japanese multinationals in Europe and the United States: Some comparisons and contrasts
JH Dunning, M Gittelman
University of Reading, Department of Economics, 1991
211991
Question‐based innovations in strategy research methods
A Arora, M Gittelman, S Kaplan, J Lynch, W Mitchell, N Siggelkow
Strategic Management Journal 37 (1), 3-9, 2016
182016
The performance and structure of Japanese affiliates in the European Community
M Gittelman, E Graham
Does ownership matter, 127-158, 1994
161994
Comment: The value of European patents
M Gittelman
European Management Review 5 (2), 85-89, 2008
132008
Transnational corporations in Europe 1992: implications for developing countries
M GITTELMAN
The CTC Reporter 29, 35-42, 1990
121990
Are licensing markets local? An analysis of the geography of vertical licensing agreements in bio-pharmaceuticals
J Alcacer, J Cantwell, M Gittelman
HBS Working paper, 2009
112009
How do I know what you know? The role of inventors and examiners in the generation of patent citations
J Alcácer, M Gittelman
Review of Economics and Statistics (forthcoming), 2004
92004
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20